Clinical Trial 43814

Winter Haven, FL 33880


Summary:

SURPASS-CVOT is a Phase 3, event-driven study. This study will assess the effect of once weekly Tirzepatide, up to 15mg, on MACE-3, compared to once weekly dulaglutide 1.5 mg, when added to the standard of care in patients with Type 2 Diabetes with established cardiovascular disease (CVD).


Qualified Participants Must:

• Be at least 40 years of age
• No cardiac events within the last 2 months
• A1C at least 7.0
• Be willing to self inject study medication once weekly


Qualified Participants May Receive:

- Study related procedures such as bloodwork, ECG, etc.

- Physical performed by a board certified physician

- Compensation for time and travel expenses


Available At:

Clinical Research of Central Florida
500 East Central Ave
Winter Haven, FL 33880
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 25 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.